2024 |
Batliboi Ltd.
|
Independent Director |
3.4 L |
157.7 % |
2023 |
Batliboi Ltd.
|
Independent Director |
1.3 L |
0.0 % |
2022 |
Batliboi Ltd.
|
Independent Director |
1.3 L |
-16.1 % |
2021 |
Larsen & Toubro Ltd.
|
Non Executive & Independent Director |
66 L |
31.2 % |
2021 |
Batliboi Ltd.
|
Independent Director |
1.6 L |
40.9 % |
2020 |
Larsen & Toubro Ltd.
|
Independent Director |
50.3 L |
-23.0 % |
2020 |
Batliboi Ltd.
|
Independent Director |
1.1 L |
-8.3 % |
2019 |
Larsen & Toubro Ltd.
|
Independent Director |
65.3 L |
30.6 % |
2019 |
Batliboi Ltd.
|
Independent Director |
1.2 L |
0.0 % |
2018 |
Larsen & Toubro Ltd.
|
Independent Director |
50 L |
-11.0 % |
2018 |
Batliboi Ltd.
|
Independent Director |
1.2 L |
9.1 % |
2017 |
Larsen & Toubro Ltd.
|
Independent Director |
56.2 L |
-8.9 % |
2017 |
Batliboi Ltd.
|
Independent Director |
1.1 L |
-26.7 % |
2016 |
Larsen & Toubro Ltd.
|
Independent Director |
61.7 L |
- |
2016 |
GlaxoSmithKline Consumer Healthcare Ltd.
|
Chairman |
21.1 L |
- |
2016 |
Tata Motors Ltd.
|
Independent Director |
8.6 L |
- |
2016 |
Batliboi Ltd.
|
Independent Director |
1.5 L |
- |